Resources ovarian cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Tumor Cells, Cultured Ovary Neoplastic Stem Cells Epithelial Cells Breast

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases76

Vulvar Neoplasms Ovarian Neoplasms Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Neoplasms Pancreatic Neoplasms Breast Neoplasms Carcinoma Neoplasms, Cystic, Mucinous, and Serous Adenocarcinoma, Mucinous Neoplasm Invasiveness Lung Neoplasms Adenocarcinoma, Clear Cell Neoplasm Metastasis Peritoneal Neoplasms Colonic Neoplasms Prostatic Neoplasms Carcinoma, Endometrioid Cystadenocarcinoma Genetic Predisposition to Disease Stomach Neoplasms Neoplasms, Multiple Primary Neoplasm Recurrence, Local Ascites Skin Neoplasms Neoplasms, Second Primary Disease Progression Cystadenocarcinoma, Mucinous Endometrial Neoplasms Colorectal Neoplasms Kidney Neoplasms Adenocarcinoma, Papillary Adenocarcinoma Uterine Cervical Neoplasms Liver Neoplasms Cystadenoma, Serous Urinary Bladder Neoplasms Thyroid Neoplasms Genital Neoplasms, Female Fallopian Tube Neoplasms Cystadenoma Gastrointestinal Neoplasms Cell Transformation, Neoplastic Neoplasms, Experimental Neoplasms, Radiation-Induced Neoplastic Syndromes, Hereditary Carcinoma, Squamous Cell Bone Neoplasms Carcinoma, Papillary Hereditary Breast and Ovarian Cancer Syndrome Rectal Neoplasms Testicular Neoplasms Mouth Neoplasms Neovascularization, Pathologic Carcinoma, Pancreatic Ductal Adenoma Carcinoma, Non-Small-Cell Lung Uterine Neoplasms Cystadenoma, Mucinous Esophageal Neoplasms Head and Neck Neoplasms Precancerous Conditions Myeloproliferative Disorders Cystadenocarcinoma, Papillary Lymphoma Intestinal Neoplasms Parotid Neoplasms Disease Models, Animal Appendiceal Neoplasms Endocrine Gland Neoplasms Neoplasms, Connective and Soft Tissue Neoplasms, Plasma Cell Breast Neoplasms, Male Nose Neoplasms Hematologic Neoplasms Neoplasms, Germ Cell and Embryonal

Chemicals and Drugs51

CA-125 Antigen Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents Cisplatin Paclitaxel DNA, Neoplasm BRCA2 Protein BRCA1 Protein Antigens, Neoplasm RNA, Messenger Carboplatin Antineoplastic Agents, Phytogenic Epididymal Secretory Proteins Cancer Vaccines RNA, Small Interfering Tumor Suppressor Protein p53 Receptor, erbB-2 RNA, Neoplasm Platinum Compounds Platinum Antibodies, Monoclonal Receptors, Estrogen Transcription Factors Antigens, Tumor-Associated, Carbohydrate Topotecan MicroRNAs Tumor Suppressor Proteins DNA-Binding Proteins Taxoids Receptors, Progesterone Receptor, Epidermal Growth Factor Proto-Oncogene Proteins Nuclear Proteins Antibodies, Neoplasm Organoplatinum Compounds Tamoxifen Proto-Oncogene Proteins c-akt Contraceptives, Oral Mucin-1 Altretamine Carcinogens Fluorouracil Deoxycytidine Prostate-Specific Antigen Antineoplastic Agents, Hormonal Antibodies, Monoclonal, Humanized Ki-67 Antigen Folate Receptor 1 DNA Primers Anticarcinogenic Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment61

Early Detection of Cancer Neoplasm Staging Prognosis Survival Analysis Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Gene Expression Profiling Survival Rate Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Retrospective Studies Risk Factors Neoplasm Transplantation Risk Follow-Up Studies Disease-Free Survival Prospective Studies Blotting, Western Sensitivity and Specificity Oligonucleotide Array Sequence Analysis Risk Assessment Treatment Outcome Genetic Testing Registries Combined Modality Therapy Neoplasm Grading Odds Ratio Neoplasms, Experimental Transplantation, Heterologous Tissue Array Analysis Polymerase Chain Reaction Kaplan-Meier Estimate Questionnaires Incidence Multivariate Analysis Case-Control Studies Drug Screening Assays, Antitumor DNA Mutational Analysis Reproducibility of Results Immunoenzyme Techniques Cohort Studies Predictive Value of Tests Transfection Chemotherapy, Adjuvant Tumor Burden Drug Administration Schedule Models, Biological Logistic Models Clinical Trials as Topic Flow Cytometry Molecular Targeted Therapy Confidence Intervals SEER Program Gene Knockdown Techniques Salpingectomy Tomography, X-Ray Computed Disease Models, Animal Biopsy Mammography Genetic Therapy Radiotherapy

Psychiatry and Psychology1

Phenomena and Processes43

Genes, BRCA1 Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genes, BRCA2 Genetic Predisposition to Disease Mutation Germ-Line Mutation Cell Proliferation Risk Apoptosis Sensitivity and Specificity DNA Methylation Cell Survival Odds Ratio Genotype Signal Transduction Cell Movement Cell Division Genes, Tumor Suppressor Time Factors Down-Regulation Dose-Response Relationship, Drug Cell Growth Processes Up-Regulation Cell Cycle Polymorphism, Genetic Transfection Phenotype Promoter Regions, Genetic Base Sequence RNA Interference Heterozygote Gene Silencing Gene Expression Genes, Neoplasm Loss of Heterozygosity Genes, p53 Alleles Drug Synergism Diet Phosphorylation Postmenopause Gene Amplification

Disciplines and Occupations5

Immunohistochemistry Medical Oncology Genetic Counseling Genomics Computational Biology

Anthropology, Education, Sociology and Social Phenomena3

Resource Allocation National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture1

Conservation of Natural Resources

Humanities1

Quality of Life

Information Science9

Survival Rate Registries Internet Questionnaires Incidence Base Sequence Molecular Sequence Data SEER Program Databases, Genetic

Named Groups2

Health Care32

Health Resources Survival Analysis Survival Rate Retrospective Studies Risk Factors Risk Follow-Up Studies Disease-Free Survival Prospective Studies Sensitivity and Specificity Risk Assessment Treatment Outcome Genetic Testing Registries Age Factors Odds Ratio Kaplan-Meier Estimate Questionnaires Incidence Multivariate Analysis Case-Control Studies Reproducibility of Results Cohort Studies Predictive Value of Tests National Cancer Institute (U.S.)Conservation of Natural Resources Logistic Models Clinical Trials as Topic Confidence Intervals SEER Program Genetic Counseling Family Health

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Ovarian Neoplasms Neoplasms, Glandular and Epithelial CA-125 Antigen Cystadenocarcinoma, Serous Neoplasms Health Resources Pancreatic Neoplasms Genes, BRCA1 Cell Line, Tumor Early Detection of Cancer Breast Neoplasms Gene Expression Regulation, Neoplastic Carcinoma Neoplasms, Cystic, Mucinous, and Serous Tumor Markers, Biological Adenocarcinoma, Mucinous Neoplasm Invasiveness Neoplasm Staging Neoplasm Proteins Drug Resistance, Neoplasm Lung Neoplasms Antineoplastic Agents Mice, Nude Prognosis Adenocarcinoma, Clear Cell Neoplasm Metastasis Peritoneal Neoplasms Cisplatin Genes, BRCA2 Paclitaxel DNA, Neoplasm Colonic Neoplasms Prostatic Neoplasms Carcinoma, Endometrioid BRCA2 Protein Survival Analysis Cystadenocarcinoma Genetic Predisposition to Disease Stomach Neoplasms BRCA1 Protein Antineoplastic Combined Chemotherapy Protocols Neoplasms, Multiple Primary Immunohistochemistry Neoplasm Recurrence, Local Gene Expression Profiling Survival Rate Mutation Ascites Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Skin Neoplasms Retrospective Studies Neoplasms, Second Primary Antigens, Neoplasm Resource Allocation Risk Factors Disease Progression Tumor Cells, Cultured Germ-Line Mutation Cystadenocarcinoma, Mucinous Neoplasm Transplantation United States Cell Proliferation RNA, Messenger Endometrial Neoplasms Risk Colorectal Neoplasms Carboplatin Follow-Up Studies Disease-Free Survival Antineoplastic Agents, Phytogenic Prospective Studies Epididymal Secretory Proteins Kidney Neoplasms Adenocarcinoma, Papillary Adenocarcinoma Uterine Cervical Neoplasms Liver Neoplasms Apoptosis Blotting, Western Cystadenoma, Serous Urinary Bladder Neoplasms Thyroid Neoplasms Sensitivity and Specificity Cancer Vaccines Ovary Genital Neoplasms, Female Oligonucleotide Array Sequence Analysis Fallopian Tube Neoplasms Risk Assessment RNA, Small Interfering Treatment Outcome Genetic Testing DNA Methylation Registries Cystadenoma Combined Modality Therapy Age Factors Tumor Suppressor Protein p53

No FAQ available that match "resources ovarian cancer vulvar neoplasms"